Navigation Links
Amylin Pharmaceuticals Provides Shareholders with Update Regarding Recent Developments
Date:4/2/2009

-traded convertible securities that we identified, 15 (58%) have similar provisions. Yet Icahn and Eastbourne have mischaracterized these provisions by falsely suggesting that they were inserted into our agreements by and for the benefit of the Board.

What are Icahn and Eastbourne trying to achieve with their actions? The fact is that any reasonable observer would have to conclude, based on their actions, that they appear to be seeking control of the Board. Their focus on the provisions in our debt agreements and their interest in the litigation certainly support that conclusion.

The Board is acting to address the change-of-control provisions in our debt agreements and fulfill our commitment to our shareholders, our debt holders and Amylin.

First, we are taking action to try to address the change-in-control provision in our convertible notes due 2014. That provision is triggered if six or more directors are elected who have not been "approved" by the existing Board. While we believe that the Board has the ability to approve any nominees proposed by Icahn or Eastbourne at any time up to the election in order to nullify the debt acceleration provision, we cannot ensure that our bondholders will concur with that view. In fact, we requested confirmation of our view from the trustee of the 2014 notes and the trustee has refused to confirm our view. To protect the company and its shareholders, this issue will need to be resolved in court.

Second, we have taken steps to address the debt acceleration provision in our senior credit agreement. We have contacted the administrative agent for that facility to request an amendment or waiver of that provision, which would be automatically triggered by a change in a majority of the Board regardless of whether or not the existing Board approves the new nominees.

The Board is dedicated to having a fair and transparent election an
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Amylin Pharmaceuticals to Present at BioCentury NewsMakers Conference, Thomas Weisel Healthcare Conference and Bear Stearns Healthcare Conference
2. Drs. John Patton of Nektar, Igor Gonda of Aradigm, Tomas Landh of Novo Nordisk, Chris Rhodes of Amylin to Speak at iiBIGs Plenary Panel in Vegas
3. Amylin Pharmaceuticals Reports Third Quarter Financial Results
4. Amylin Pharmaceuticals to Present at BIOCOM Investor Conference
5. Amylin Pharmaceuticals Elects Adrian Adams to Board of Directors
6. Xenome Receives a Syndicated US$10 Million Equity Investment from Queensland BioCapital Fund, Amylin Pharmaceuticals and Innovis Investment Partners
7. Amylin Pharmaceuticals to Present at Nasdaq 20th Investor Program
8. Amylin Pharmaceuticals to Present at Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
9. Amylin Pharmaceuticals to Webcast First Quarter Results
10. Amylin Pharmaceuticals to Present at Morgan Stanley Global Healthcare Unplugged Conference
11. Amylin Pharmaceuticals Announces Time Change to Previously Announced Presentation at the Morgan Stanley Global Healthcare Unplugged Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/12/2014)... Albany, New York (PRWEB) July 12, 2014 ... market analysis for various reagents used in ... biotechnology is driving the life science reagents ... this study include manufacturers and providers of ... Science Reagents Market Report: http://www.transparencymarketresearch.com/life-sciences-reagents-analytical-reagents.html . ...
(Date:7/11/2014)... , July 11, 2014 ... to announce the appointment of John P. Donoghue ... Biotech   in  Geneva . The ... Campus Biotech in Geneva , has ... recognised neuroscientists. John P. Donoghue , founder of ...
(Date:7/10/2014)... 2014 Product and process impurities ... abundance and are often “lost in the noise,” ... Join presenters Dr. Rowel Tobias, Senior Scientist, Protein ... Head of Quality at Nanotherapeutics, Inc., to lear ... speed detection and quantitation while achieving the required ...
(Date:7/10/2014)... Robert Harman, DVM, Founder and CEO of Vet-Stem, ... announce the relaunch of his highly informative blog, now named ... “ What are Stem Cells ?” Dr. Harman’s purpose ... in the basics of stem cell therapy so that pet ... of treatment when considering regenerative medicine. , A veterinarian by ...
Breaking Biology Technology:Transparency Market Research: Life Science Reagents Market- PCR Reagent Kits, Cell and Tissue Culture, Flow Cytometry, Electrophoresis and Chromatography 2Transparency Market Research: Life Science Reagents Market- PCR Reagent Kits, Cell and Tissue Culture, Flow Cytometry, Electrophoresis and Chromatography 3John P. Donoghue is Taking the Lead at the Wyss Center and is Appointed Professor at EPFL and University of Geneva 2John P. Donoghue is Taking the Lead at the Wyss Center and is Appointed Professor at EPFL and University of Geneva 3Novel Ms Techniques Speed Detection of Biopharmaceutical Product and Process Impurities, New Webinar Hosted by Xtalks 2Robert Harman, DVM Talks About What Stem Cells are in His Latest Blog Series for Vet-Stem, Inc. 2Robert Harman, DVM Talks About What Stem Cells are in His Latest Blog Series for Vet-Stem, Inc. 3
... platform offers multiple diagnostic modalities on a single ... to ... physicians and administrators, SAN DIEGO, March 28 ... of intravascular,ultrasound (IVUS), functional measurement (FM) and Optical Coherence,Tomography (OCT) ...
... /Xinhua-PRNewswire/ -- Tiens Biotech Group (USA),Inc. ("the Company" or ... financial results for the fourth quarter and twelve months ... of 2007 was $13.3 million compared to,$16.6 million for ... the fourth quarter of 2007 was $3.9 million, or ...
... -. Actavis Group, the,international generic pharmaceuticals company, ... approvals from the U.S. Food & Drug ... Distribution,of the products will commence immediately., ... strength, are the generic equivalent of Wellbutrin ...
Cached Biology Technology:Volcano Announces U.S. and European Launch of Rotational IVUS and Integrated FFR 2Volcano Announces U.S. and European Launch of Rotational IVUS and Integrated FFR 3Volcano Announces U.S. and European Launch of Rotational IVUS and Integrated FFR 4Volcano Announces U.S. and European Launch of Rotational IVUS and Integrated FFR 5Tiens Biotech Group (USA) Reports Fourth Quarter and Twelve-Month Results 2Tiens Biotech Group (USA) Reports Fourth Quarter and Twelve-Month Results 3Tiens Biotech Group (USA) Reports Fourth Quarter and Twelve-Month Results 4Tiens Biotech Group (USA) Reports Fourth Quarter and Twelve-Month Results 5Tiens Biotech Group (USA) Reports Fourth Quarter and Twelve-Month Results 6Tiens Biotech Group (USA) Reports Fourth Quarter and Twelve-Month Results 7Tiens Biotech Group (USA) Reports Fourth Quarter and Twelve-Month Results 8Tiens Biotech Group (USA) Reports Fourth Quarter and Twelve-Month Results 9Tiens Biotech Group (USA) Reports Fourth Quarter and Twelve-Month Results 10Actavis Receives Approval of Generic Wellbutrin SR(R) and Zyban(R) Tablets in the U.S. 2
(Date:7/11/2014)... evidence that under the normal circumstances, astrocytes ... maintain neuronal environment, and exhibit therapeutic and ... disease. Previous studies have found that nerve ... chemical induction have reduced viability, which produces ... Xiaodong Yuan, Kailuan General Hospital, Hebei United ...
(Date:7/11/2014)... , July 11, 2014 Research ... "International Biometrics Technology Market - Industry Analysis Size ... to their offering. http://photos.prnewswire.com/prnh/20130307/600769 ... and crimes has created a need for high level ... used for personnel authentication such as username and passwords, ...
(Date:7/11/2014)... Janeiro, Brazil- In the brains of all vertebrates, ... allows an electric or chemical signal to be ... synapses, which are the most abundant type of ... formation is crucial for learning, memory, perception and ... synapses critical for brain function. For instance, ...
Breaking Biology News(10 mins):International Biometrics Technology Market - Industry Analysis Size Share Growth Trends and Forecast to 2019 2Blame it on the astrocytes 2
... has made new links between 29 regions of the genome ... disease (IBD). The new findings increase the total number of ... to 99. The results point to several biological processes, ... the intestinal wall, which are likely to play an important ...
... With millions of people warding off winter,s chill with ... flags about the potential health effects of the smoke ... American Chemical Society,s (ACS,) journal, Chemical Research in ... the lungs from wood smoke may have several adverse ...
... they seem when it comes to fishsomething scientists at the ... Using modern genetic analysis, combined with traditional examination of morphology, ... three species of blenny in the genus Starksia ... in the scientific journal ZooKeys , Feb. 3. ...
Cached Biology News:Research links 29 genome regions with common form of inflammatory bowel disease 2Research links 29 genome regions with common form of inflammatory bowel disease 3Smithsonian scientists discover 7 new species of fish 2